Enterprise value:
$123.64B+$12.84M(+0.01%)Summary
- As of today (April 25, 2025), VRTX enterprise value is $123.64 billion, with a rise of +$12.84 million (+0.01%) during the most recent trading session on April 24, 2025.
- Over the past year, VRTX enterprise value has increased by +$27.34 billion (+28.39%).
- VRTX enterprise value is now -4.22% below its all-time high of $129.09 billion.
Performance
VRTX Enterprise value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Enterprise value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
VRTX Enterprise value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +0.0% | +0.0% | +0.0% |
| 1 m1 month | -3.9% | -3.8% | -3.8% |
| 3 m3 months | +12.3% | +12.0% | +12.0% |
| 6 m6 months | - | +3.9% | +4.4% |
| ytdytd | +25.0% | +24.3% | +22.3% |
| 1 y1 year | +28.4% | +20.7% | +22.9% |
| 5 y5 years | +84.8% | +80.7% | +82.5% |
VRTX Enterprise value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | $129B | -3.9% | $118B | +4.4% |
| 3 m | 3-month | $129B | -4.2% | $110B | +12.3% |
| 6 m | 6-month | $129B | -4.2% | $97.88B | +26.3% |
| 1 y | 1-year | $129B | -4.2% | $92.52B | +33.6% |
| 3 y | 3-year | $129B | -4.2% | $53.36B | +131.7% |
| 5 y | 5-year | $129B | -4.2% | $39.95B | +209.5% |
| alltime | all time | $129B | -4.2% | $60.46M | >+9999.0% |
Vertex Pharmaceuticals Incorporated Enterprise value History
| Date | Value |
|---|---|
| 2025 | $123.64B(+25.0%) |
| 2024 | $98.93B(+53.1%) |
| 2022 | $64.62B(+29.1%) |
| 2021 | $50.06B(-11.2%) |
| 2020 | $56.37B(+3.9%) |
| 2019 | $54.26B(+34.9%) |
| 2018 | $40.22B(+9.0%) |
| 2017 | $36.89B(+105.5%) |
| 2016 | $17.95B(-42.3%) |
| 2015 | $31.10B(+7.5%) |
| 2014 | $28.92B(+67.1%) |
| 2013 | $17.31B(+85.9%) |
| 2012 | $9.31B(+34.3%) |
| 2011 | $6.93B(-6.6%) |
| 2010 | $7.42B(-10.3%) |
| 2009 | $8.28B(+85.1%) |
| 2008 | $4.47B(+62.5%) |
| Date | Value |
|---|---|
| 2007 | $2.75B(-40.6%) |
| 2006 | $4.63B(+49.6%) |
| 2005 | $3.09B(+173.0%) |
| 2004 | $1.13B(+8.7%) |
| 2003 | $1.04B(-27.1%) |
| 2002 | $1.43B(-27.9%) |
| 2001 | $1.98B(-53.6%) |
| 2000 | $4.28B(+389.2%) |
| 1999 | $874.49M(+18.2%) |
| 1998 | $740.03M(-3.8%) |
| 1997 | $769.03M(-6.5%) |
| 1996 | $822.75M(+88.3%) |
| 1995 | $437.02M(+126.9%) |
| 1994 | $192.63M(-4.9%) |
| 1993 | $202.62M(+80.6%) |
| 1992 | $112.20M(-25.4%) |
| 1991 | $150.31M |
FAQ
- What is Vertex Pharmaceuticals Incorporated enterprise value?
- What is the all time high enterprise value for Vertex Pharmaceuticals Incorporated?
- What is VRTX enterprise value year-to-date change?
- What is Vertex Pharmaceuticals Incorporated enterprise value year-on-year change?
What is Vertex Pharmaceuticals Incorporated enterprise value?
The current enterprise value of VRTX is $123.64B
What is the all time high enterprise value for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high enterprise value is $129.09B
What is VRTX enterprise value year-to-date change?
Vertex Pharmaceuticals Incorporated enterprise value has changed by +$24.72B (+24.98%) since the beginning of the year
What is Vertex Pharmaceuticals Incorporated enterprise value year-on-year change?
Over the past year, VRTX enterprise value has changed by +$27.34B (+28.39%)